Premier Anti-Aging Co., Ltd. (TYO:4934)
730.00
+6.00 (0.83%)
Mar 10, 2026, 3:30 PM JST
Premier Anti-Aging Income Statement
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| Revenue | 15,573 | 16,160 | 20,359 | 26,400 | 33,911 | 32,815 |
| Revenue Growth (YoY) | -19.41% | -20.63% | -22.88% | -22.15% | 3.34% | - |
| Cost of Revenue | 3,741 | 3,774 | 4,258 | 7,158 | 7,283 | 6,385 |
| Gross Profit | 11,832 | 12,386 | 16,101 | 19,242 | 26,628 | 26,430 |
| Selling, General & Admin | 11,260 | 11,768 | 15,961 | 19,854 | 24,214 | 21,702 |
| Other Operating Expenses | - | - | - | - | - | 47 |
| Operating Expenses | 11,260 | 11,768 | 15,961 | 19,874 | 24,214 | 21,749 |
| Operating Income | 572 | 618 | 140 | -632 | 2,414 | 4,681 |
| Interest Expense | -15 | -19 | -22 | -18 | -14 | -14 |
| Interest & Investment Income | 7 | 3 | 1 | 1 | 1 | - |
| Currency Exchange Gain (Loss) | 9 | -12 | 35 | -4 | 136 | - |
| Other Non Operating Income (Expenses) | 9 | 9 | 7 | 22 | 34 | -15 |
| EBT Excluding Unusual Items | 582 | 599 | 161 | -631 | 2,571 | 4,652 |
| Gain (Loss) on Sale of Investments | 20 | 20 | -2 | - | - | - |
| Asset Writedown | -32 | -32 | -531 | -27 | - | - |
| Other Unusual Items | - | - | -530 | -1 | - | - |
| Pretax Income | 570 | 587 | -902 | -659 | 2,571 | 4,652 |
| Income Tax Expense | 105 | 116 | 581 | 74 | 1,147 | 1,859 |
| Net Income | 465 | 471 | -1,483 | -733 | 1,424 | 2,793 |
| Net Income to Common | 465 | 471 | -1,483 | -733 | 1,424 | 2,793 |
| Net Income Growth | - | - | - | - | -49.02% | - |
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 |
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 |
| Shares Change (YoY) | 0.14% | 0.13% | - | -0.14% | 2.03% | - |
| EPS (Basic) | 53.32 | 54.01 | -170.06 | -84.06 | 163.30 | 326.80 |
| EPS (Diluted) | 53.32 | 54.01 | -170.06 | -84.06 | 163.11 | 326.38 |
| EPS Growth | - | - | - | - | -50.02% | - |
| Free Cash Flow | - | 1,442 | -204 | 2,395 | -3,349 | 2,748 |
| Free Cash Flow Per Share | - | 165.15 | -23.39 | 274.64 | -383.49 | 321.05 |
| Gross Margin | 75.98% | 76.65% | 79.09% | 72.89% | 78.52% | 80.54% |
| Operating Margin | 3.67% | 3.82% | 0.69% | -2.39% | 7.12% | 14.27% |
| Profit Margin | 2.99% | 2.92% | -7.28% | -2.78% | 4.20% | 8.51% |
| Free Cash Flow Margin | - | 8.92% | -1.00% | 9.07% | -9.88% | 8.37% |
| EBITDA | 882 | 916 | 390 | -424 | 2,499 | 4,725 |
| EBITDA Margin | 5.66% | 5.67% | 1.92% | -1.61% | 7.37% | 14.40% |
| D&A For EBITDA | 310 | 298 | 250 | 208 | 85 | 44 |
| EBIT | 572 | 618 | 140 | -632 | 2,414 | 4,681 |
| EBIT Margin | 3.67% | 3.82% | 0.69% | -2.39% | 7.12% | 14.27% |
| Effective Tax Rate | 18.42% | 19.76% | - | - | 44.61% | 39.96% |
| Advertising Expenses | - | 3,924 | 6,358 | 8,598 | 12,920 | 12,812 |
Source: S&P Capital IQ. Standard template. Financial Sources.